Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
6.2 Novo Nordisk + Septerna (May 2025, up to $2.2B) Novo's second major triple-agonist transaction was a broader small-molecule GPCR collaboration with Septerna announced May 2025: up to $2.2 billion total deal value, $200 million+ upfront, covering four oral small-molecule GPCR programs
79 Tijerina GonzlezL
When someone asks about your semaglutide dose, give the answer in milligrams and mention your concentration
Prescription weight loss medications, approved by the Food and Drug Administration (FDA), are specifically designed to aid those with a high body mass index (BMI) or other serious health conditions
US$ 28.05
US$ 23.83
US$ 28.81
US$ 25.89
US$ 25.93
US$ 28.66
